Bernstein double upgrades Rentokil to 'outperform', hikes price target
Bernstein doubled upgraded Rentokil Initial Plc on Tuesday to 'outperform' from 'underperform' and hiked the price target to 570p from 313p, saying it sees signs of inflecting organic revenue growth.
The bank also said it believes that Rentokil can enjoy structural growth in line with the industry, combined with ongoing consolidation.
"Given cost and free cash flow levers available to the group under the stewardship of Paul as CFO we consider EBITA levels well underpinned," Bernstein said.
"This, combined with FCF enhancing initiatives, could considerably enhance the return on invested capital profile of the group."
The bank said that with a new CEO yet to be announced, it runs the risk of being early but upside pressure is starting to build, and it sees it as increasingly likely that investors will place a greater value on the Pest business on first signs of progress.
At 1115 BST, the shares were up 2.4% at 403.86p.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
